Except for anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphoma (ALK+ALCL), the majority of subtypes have poor prognosis, with a 5-year overall survival (OS) of about 14–56% [6–9]. Here, ALK is linked to anaplastic large cell lymphoma.